Benefit-risk of ofatumumab in treatment-naive early relapsing multiple sclerosis patients

被引：0

作者：

Gartner, J. ^{[1
]}

Hauser, S. ^{[2
]}

Bar-Or, A. ^{[3
,4
]}

Montalban, X. ^{[5
]}

Cohen, J. ^{[6
]}

Cross, A. H. ^{[7
]}

Deiva, K. ^{[8
]}

Haring, D. A. ^{[9
]}

Li, B. ^{[10
]}

Pingili, R. ^{[10
]}

Ramanathan, K. ^{[9
]}

Su, W. ^{[10
]}

Kappos, L. ^{[11
,12
,13
,14
,15
]}

机构：

[1] Georg August Univ Gottingen, Dept Paediat & Adolescent Med, Univ Med Ctr Gottingen, Div Paediat Neurol, Gottingen, Germany

[2] Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, San Francisco, CA USA

[3] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA

[4] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA

[5] Hosp Univ Vall dHebron, Dept Neurol Neuroimmunol, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain

[6] Cleveland Clin, Neurol Inst, Dept Neurol, Mellen MS Ctr, Cleveland, OH 44106 USA

[7] Washington Univ, Sch Med, Dept Neurol, Div Neuroimmunol, St Louis, MO 63110 USA

[8] Univ Hosp Paris Saclay, Dept Pediat Neurol, Hop Bicetre, Natl Reference Ctr Rare Inflammatory Brain & Spin, Le Kremlin Bicetre, France

[9] Novartis Pharma AG, Basel, Switzerland

[10] Novartis Pharmaceut, E Hanover, NJ USA

[11] Univ Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland

[12] Univ Hosp, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland

[13] Univ Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland

[14] Univ Hosp, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland

[15] Univ Basel, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0192

引用

页码：210 / 210

页数：1